RNU7-7P

Across TCGA pan-cancer cohorts, RNU7-7P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RNU7-7P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RNU7-7P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RNU7-7P expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

OV, LIHC, and HNSC are the cancer types where RNU7-7P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	III,IV	0.327	0.146	.011	78	view →
LIHC	DFS	Tertile	All	0.076	0.553	.002	72	view →
HNSC	DFS	Tertile	All	0.138	0.626	.006	36	view →
BLCA	OS	Tertile	All	0.195	0.720	.003	27	view →
GBM	DFS	Tertile	All	0.071	0.288	.009	18	view →
BRCA	DFS	Tertile	All	0.261	0.532	.021	12	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RNU7-7P–OV (DFS)

Open the OV breakdown →